EV/EBITDA
7.95
-0.14-1.73%
Fri, 21 Feb 2025 23:27:48 GMT
Summary
- As of February 22, 2025, OTLK EV/EBITDA is 7.95, with a fall of -0.14 (-1.73%) during the most recent trading day.
- Over the past year, OTLK EV/EBITDA has increased by +10.61 (+398.87%).
- OTLK EV/EBITDA is now -91.71% below its all-time high of 95.93.
Performance
OTLK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
OTLK EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.7% | -1.7% | -2.5% |
| 1 m1 month | -20.5% | -20.4% | -27.8% |
| 3 m3 months | +21.0% | -44.2% | -68.7% |
| 6 m6 months | -89.5% | -55.0% | -77.6% |
| ytdytd | +5.0% | +5.1% | -16.1% |
| 1 y1 year | +398.9% | -43.0% | -80.7% |
| 5 y5 years | +671.9% | +41.5% | -91.5% |
OTLK EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -20.5% | 7.95 | at low | |
| 3 m | 3-month | 10.00 | -20.5% | 2.29 | +247.2% |
| 6 m | 6-month | 82.67 | -90.4% | 2.29 | +247.2% |
| 1 y | 1-year | 95.93 | -91.7% | -5.76 | +238.0% |
| 3 y | 3-year | 95.93 | -91.7% | -8.62 | +192.2% |
| 5 y | 5-year | 95.93 | -91.7% | -16.32 | +148.7% |
| alltime | all time | 95.93 | -91.7% | -16.32 | +148.7% |
Outlook Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 7.95(+5.0%) |
| 2024 | 7.57(-398.0%) |
| 2023 | -2.54(-33.9%) |
| 2022 | -3.84(-22.7%) |
| 2021 | -4.97(+0.4%) |
| Date | Value |
|---|---|
| 2020 | -4.95(+438.0%) |
| 2019 | -0.92(-52.8%) |
| 2018 | -1.95(-15.9%) |
| 2017 | -2.32(+48.7%) |
| 2016 | -1.56 |
FAQ
- What is Outlook Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Outlook Therapeutics?
- What is OTLK EV/EBITDA year-to-date change?
- What is Outlook Therapeutics EV/EBITDA year-on-year change?
What is Outlook Therapeutics EV/EBITDA?
The current EV/EBITDA of OTLK is 7.95
What is the all time high EV/EBITDA for Outlook Therapeutics?
Outlook Therapeutics all-time high EV/EBITDA is 95.93
What is OTLK EV/EBITDA year-to-date change?
Outlook Therapeutics EV/EBITDA has changed by +0.38 (+5.02%) since the beginning of the year
What is Outlook Therapeutics EV/EBITDA year-on-year change?
Over the past year, OTLK EV/EBITDA has changed by +10.61 (+398.87%)